How Apple raised the price of the iPhone
Base price of unlocked iPhone 5s to iPhone Max (US$)
CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.
Does a combination of falling sales and higher prices spell trouble for Apple?
It has not been a month since Apple last hit an all-time high. Yet many will wonder how the giant can achieve this when iPhone sales continue to weaken.
The answer is not hard to find. A quick look at iPhone prices show that the firm has pulled off a remarkable feat, namely it is selling iPhones for higher prices at each release, despite the fact that the product itself has been around for over ten years. By now, so the theory goes, the product should have become much cheaper. But that is not happening, as the chart from the Financial Times shows:
Base price of unlocked iPhone 5s to iPhone Max (US$)
Base price of unlocked iPhone 5s to iPhone Max (US$)
The iPhones now regularly cross the $1000 barrier, and there seems no chance of the trend changing direction. CNN, using Apple’s data, has found that iPhone sales have dropped back from their peak in 2016:
Apple has found its place as a luxury brand, and seems content to let others dominate the cheaper end of the market. And this is no bad thing. From a valuation perspective, it is now more expensive on a forward price-earnings (PE) basis than at any time since 2010. Its forward PE of 16.6 is now comfortably above its five-year average of 13.2.
But as a luxury firm, Apple’s valuation would not be undemanding from a comparative perspective. The S&P Luxury Index has a forward PE of 17, so Apple would fit comfortably within that. This reduces the potential for nasty surprises.
Of course, it is possible that the decline in sales will outpace the increase in price of new models. In which case, Apple is in trouble. And admittedly it has to deal with a demanding valuation, so the risk of disappointment will increase. Investors can hardly argue with the momentum and fundamentals shown by the shares, but chasing them at all-time highs may not be the best strategy.
On average, September sees some weakness for Apple shares. Over the past 20 years, September is in fact the weakest month of the year, down 1.3%. But that is followed by an average 7% gain in October, 3.1% in November and 0.4% in December. The seasonality chart, to all intents and purposes, is a straight line:
Apple stock saw a significant retracement in June, but this latest sell-off merely provided the excuse for new longs to pile in. At present, the stock has struggled around $220, but any major pullback will simply fall into the ‘buying opportunity’ category until we see a move below $175 in the near term.
IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
See important Research Disclaimer.